Multiple myeloma has been one of the most studied malignancies since its discovery in the mid-nineteenth century. During the last decade, knowledge about the disease has advanced rapidly. Modern techniques have, for the first time, allowed real improvement both in understanding of the disease's pathogenesis and in clinical diagnosis and management, so that primary patients with advanced disease now have a greatly enhanced chance of survival. This book sets out, clearly and logically, the current options for clinical practice.
Multiple Myeloma provides a comprehensive and authoritative account of the condition emphasizing current diagnosis and management. The book examines the impact that new sophisticated techniques (such as immunophenotyping, cell sorting, cytogenetics, growth-factor analysis, and molecular biology) have had on our understanding of the disease. New treatment methods have not been introduced without difficutlies, and the risk factors of intensive antibacterial and antiviral therapies and transplantation are fully discussed. The contributors are all recognized experts in the field with "hands on" experience, making this invaluable reading for oncologists and hematologists.
